Thirty-Day Readmissions and Predictors of Adverse Outcomes After Bronchoscopic Lung Volume Reduction in the United States, 2019-2022
{{output}}
Background: Bronchoscopic lung volume reduction (BLVR) using endobronchial valves (EBV) is an established therapy for advanced emphysema; however, real-world post-discharge outcomes remain incompletely characterized. ... ...
